David I Quinn Selected Research

David I Quinn Research Topics

Disease

87	Neoplasms (Cancer) 02/2024 - 03/2003
68	Prostatic Neoplasms (Prostate Cancer) 03/2024 - 02/2002
30	Renal Cell Carcinoma (Grawitz Tumor) 11/2023 - 10/2003
28	Carcinoma (Carcinomatosis) 01/2023 - 03/2003
16	Neoplasm Metastasis (Metastasis) 02/2024 - 03/2006
16	Urinary Bladder Neoplasms (Bladder Cancer) 10/2023 - 05/2005
10	Disease Progression 11/2022 - 08/2011
10	Pain (Aches) 01/2022 - 12/2008
9	Kidney Neoplasms (Kidney Cancer) 11/2023 - 10/2007
8	Circulating Neoplastic Cells 10/2022 - 04/2014
8	Fatigue 01/2022 - 10/2007
5	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 12/2021 - 06/2006
4	Transitional Cell Carcinoma 01/2021 - 09/2003
3	Bone Resorption 02/2024 - 04/2014
3	Hypertension (High Blood Pressure) 01/2022 - 03/2015
3	Fever (Fevers) 07/2017 - 10/2007
3	Exanthema (Rash) 09/2014 - 02/2012
3	Margins of Excision 01/2014 - 04/2003
2	Hyperphosphatemia 12/2020 - 01/2018
2	Nausea 02/2019 - 04/2015
2	Adrenocortical Carcinoma 01/2019 - 04/2015
2	Non-Muscle Invasive Bladder Neoplasms 07/2017 - 06/2017

Drug/Important Bio-Agent (IBA)

21	AndrogensIBA 03/2024 - 07/2003
19	Prostate-Specific Antigen (Semenogelase)IBA 03/2024 - 04/2003
17	Biomarkers (Surrogate Marker)IBA 02/2024 - 03/2003
14	Hormones (Hormone)IBA 03/2024 - 03/2003
14	Docetaxel (Taxotere)FDA Link 04/2020 - 02/2006
13	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2019 - 10/2003
12	PlatinumIBA 01/2022 - 10/2010
11	sipuleucel-T (APC8015)FDA Link 01/2023 - 08/2011
10	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 02/2009
8	Alkaline PhosphataseIBA 02/2024 - 08/2013
6	AntigensIBA 11/2022 - 03/2009
6	ErbB Receptors (EGF Receptor)IBA 10/2022 - 12/2009
6	pembrolizumabIBA 01/2022 - 01/2017
6	Tyrosine Kinase InhibitorsIBA 01/2022 - 12/2009
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2003
5	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2021
5	LigandsIBA 01/2023 - 01/2017
5	Androgen Receptors (Androgen Receptor)IBA 01/2023 - 04/2005
5	Gemcitabine FDA Link 10/2019 - 12/2008
4	bicalutamide (Casodex)FDA LinkGeneric 03/2024 - 05/2015
4	orteronelIBA 03/2024 - 10/2022
4	Sunitinib (Sutent)FDA Link 10/2023 - 11/2018
4	infigratinibIBA 01/2022 - 01/2018
4	Prednisone (Sone)FDA LinkGeneric 10/2019 - 12/2008
4	Bevacizumab (Avastin)FDA Link 02/2019 - 07/2012
4	Sorafenib (BAY 43-9006)FDA Link 02/2019 - 01/2014
4	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 11/2018 - 04/2006
4	Gonadotropin-Releasing Hormone (GnRH)FDA Link 12/2017 - 04/2013
3	collagen type I trimeric cross-linked peptideIBA 02/2024 - 04/2014
3	CollagenIBA 02/2024 - 04/2014
3	pyridinolineIBA 02/2024 - 04/2014
3	Messenger RNA (mRNA)IBA 01/2023 - 06/2005
3	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2023 - 12/2020
3	atezolizumabIBA 01/2023 - 01/2017
3	enfortumab vedotinIBA 01/2022 - 01/2020
3	Radium-223IBA 12/2019 - 06/2015
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2019 - 07/2012
3	CreatinineIBA 10/2019 - 01/2018
3	Hemoglobins (Hemoglobin)IBA 10/2019 - 04/2014
3	Phosphotransferases (Kinase)IBA 01/2019 - 11/2015
3	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2017 - 02/2009
3	AtrasentanIBA 01/2017 - 08/2013
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2017 - 12/2008
2	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 01/2014
2	Axitinib (AG 013736)IBA 10/2023 - 03/2015
2	Cell-Free Nucleic AcidsIBA 10/2023 - 01/2020
2	abirateroneIBA 01/2023 - 01/2019
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2022 - 12/2009
2	B7-H1 AntigenIBA 01/2022 - 01/2017
2	Histone Deacetylase InhibitorsIBA 01/2021 - 12/2017
2	Immunoconjugates (Immunoconjugate)IBA 01/2021 - 12/2020
2	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 12/2020 - 01/2018
2	Monoclonal AntibodiesIBA 01/2020 - 06/2010
2	cixutumumabIBA 01/2020 - 05/2015
2	eribulin FDA Link 10/2019 - 11/2015
2	pazopanib FDA Link 02/2019 - 11/2018
2	Diphosphonates (Bisphosphonates)IBA 01/2019 - 08/2013
2	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2018 - 12/2008
2	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 12/2017 - 12/2014
2	Interleukin-2 (IL2)IBA 12/2017 - 12/2005
2	lysine(6)-doxorubicin LHRHIBA 12/2017 - 12/2014
2	taxaneIBA 12/2017 - 12/2014
2	Carboplatin (JM8)FDA LinkGeneric 09/2017 - 12/2008
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2017 - 03/2003
2	TOR Serine-Threonine KinasesIBA 07/2017 - 01/2016
2	cabazitaxel FDA Link 02/2017 - 10/2010

Therapy/Procedure

62	Therapeutics 03/2024 - 07/2003
41	Drug Therapy (Chemotherapy) 10/2023 - 05/2005
36	Castration 04/2023 - 03/2009
15	Prostatectomy (Retropubic Prostatectomy) 01/2021 - 02/2002
11	Cystectomy 10/2023 - 09/2003
11	Immunotherapy 01/2021 - 12/2011
8	Radiotherapy 01/2021 - 06/2004
5	Adjuvant Chemotherapy 12/2014 - 05/2005
4	Nephrectomy 10/2023 - 11/2018
4	Neoadjuvant Therapy 10/2023 - 12/2008
3	Aftercare (After-Treatment) 01/2023 - 05/2007
2	Salvage Therapy 01/2022 - 11/2003